Directors' Options

RNS Number:4305U
Henderson Morley PLC
04 April 2007

FOR IMMEDIATE RELEASE                                              04 APRIL 2007


                              HENDERSON MORLEY PLC
                                     (AIM)

                            Business: Drug Discovery

                               DIRECTORS' OPTIONS

The Board of Henderson Morley plc, the AIM listed drug discovery company, 
announces today that it has granted options over 2,500,000 Ordinary Shares at an 
exercise price of 2.25p to Chairman Andrew Knight, options over 2,500,000 
Ordinary Shares at an exercise price of 2.25p to Chief Executive Dr Ian Pardoe 
and options over 800,000 Ordinary Shares at an exercise price of 2.25p to 
Finance Director Christopher Pate. These options are exercisable for a period of 
five years from 1 May 2007.

                                    --ENDS--


Enquiries:

HENDERSON MORLEY PLC                                          Tel: 0121 442 4600
Andrew Knight, Chairman

BISHOPSGATE COMMUNICATIONS LTD                                Tel: 020 7562 3350
Maxine Barnes
Nick Rome

BREWIN DOLPHIN SECURITIES LTD                                 Tel: 0113 241 0126
Neil Baldwin


Further information on Henderson Morley plc can be accessed through the
Company's website at www.henderson-morley.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSUUUBUCUPMGWC

Henderson Mrly. (LSE:HML)
過去株価チャート
から 7 2024 まで 8 2024